Iovance Biotherapeutics, Inc. IOVA Total Operating Expenses
Discontinued — last reported Q1 '23
Total Operating Expenses at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 10, 2023, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s total operating expenses?
- Iovance Biotherapeutics, Inc. (IOVA) reported total operating expenses of $110.86M in Q1 2023.
- How has Iovance Biotherapeutics, Inc.'s total operating expenses changed year-over-year?
- Iovance Biotherapeutics, Inc.'s total operating expenses increased by 20.9% year-over-year, from $91.71M to $110.86M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.